Regeneron Pharmaceuticals, Inc. - Company Profile and SWOT Analysis
SummaryRegeneron Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Regeneron Pharmaceuticals, Inc. (Regeneron or 'the company') discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious diseases. The company offer drugs for patients with cancer, eye diseases, cardiovascular and metabolic diseases, allergic and inflammatory diseases, infectious diseases, neuromuscular diseases, rare diseases, and asthma. Its major drugs include Dupixent injection, Eylea injection, Arcalyst injection, Praluent injection, Libtayo Injection and Kevzara injection. Regeneron sells its products to various distributors and specialty pharmacies in the US. It has business operations in in Limerick, Ireland and Rensselaer, New York, the US. The company is headquartered in Tarrytown, New York, the US.
Scope
- Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Regeneron Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Regeneron Pharmaceuticals, Inc.'s business structure, strategy and prospects.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.